In every issue of POZ, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
This excerpt from Peter Staley’s memoir, “Never Silent: ACT UP and My Life in Activism,” takes place as aids activism blossoms.
Claim your place at our community table.
We can better support those living with—and at risk of contracting—HIV by choosing our words carefully.
There are many ways to be of service through HIV advocacy.
Understand what matters most about clinical trial endpoints for both advocates and researchers.
ACT UP Los Angeles members launch an oral history project. [SLIDESHOW]
Want to learn more about historic AIDS activist group ACT UP? You’re in luck. This primer will educate, inspire and even entertain!
“Growing up a Black, gay, HIV-positive man, I never thought I would be able to serve my community in this capacity,” says Venton Jones.
The nonprofit has “worked diligently to train and mobilize a new generation of public health leaders.”
On World AIDS Day, December 1, the White House released the latest National HIV/AIDS Strategy.
These dates represent milestones in the HIV epidemic. Visit poz.com/aidsiseveryday to learn more about the history of HIV/AIDS
The Sixth Annual POZ Awards spotlighted HIV/AIDS in media and culture.
Tom Kirdahy, the late playwright’s spouse, honors him in a speech given on World AIDS Day.
AIDS service organizations (ASOs) and HIV/AIDS advocates persevere—despite the COVID-19 pandemic.
Taking your medications as prescribed helps you get the most from HIV treatment.
Stigmatizing comments and experiences may be partly to blame for lower adherence.
But sustained viral suppression over time remains a challenge.
Mental health conditions and heart disease are driving rising rates of polypharmacy and multimorbidity among people living with HIV.
Studies suggest that screening people living with HIV for heart disease may improve longevity.
The Food and Drug Administration approved Apretude as the first long-acting injectable option for pre-exposure prophylaxis.
Islatravir, a long-acting antiretroviral, has hit a snag after clinical trial participants experienced falling white blood cell counts.
The International AIDS Society has launched a new global research strategy for working toward a broadly applicable cure for HIV.
Impaired ability to communicate can impact care and quality of life for deaf people aging with HIV
How much alcohol can I safely drink?
Kalee Garland is on a mission to end HIV-related stigma.
Read the digital edition!